The US FSOC annual report no longer lists cryptocurrencies as a potential threat
ChainCatcher news, according to a report by Coindesk, the United States Financial Stability Oversight Council (FSOC) has removed its warning on digital asset vulnerabilities in its latest annual report. This regulatory body, established after the 2008 financial crisis, had previously listed digital assets as one of the risks to the financial system every year.
Treasury Secretary Bessant stated in the report that financial stability requires not only focusing on risks but also promoting long-term economic growth. The 2025 report was reduced from 140 pages to 87 pages, completely removing the term "vulnerability" and no longer expressing explicit concerns or regulatory recommendations for the crypto industry. Instead, the report praised the industry's strengths and pointed out that US dollar stablecoins help consolidate the dollar's position in the international financial system.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Supply disruptions ease, oil market bears “swiftly gather”: Brent put option bets surge to unprecedented levels
Oil traders are flocking to buy options, betting on a decline in Brent crude. As investors reposition after a sharp rise in oil prices over the past few trading sessions, bearish bets have surged to unprecedented levels.

Bridgford Foods VP Richard Eugene Bridgford acquires USD 2,054.5 in common shares
New York Federal Reserve official: U.S. Treasury purchases have no preset path, will closely monitor financing market pressures in October
Lorie K. Logan, head of the New York Fed's Markets Group, stated that the Federal Reserve will continue to assess the reserve levels within the banking system. The purchase of U.S. Treasuries for reserve management does not follow a predetermined path and may be adjusted in the future based on market conditions.
Structure Therapeutics CMO Blas Coll Crespo disposes of USD 124,008 common shares
